tisotumab vedotin-tftv
genmab,seagen
['tivdak', '$sgen', 'seagen']
$sgen [15s. delayed]: issued press release on june 06, 11:00:00: seagen and genmab present data from tisotumab vedotin (tivdak ) clinical development program and additional cervical cancer research at asco 2022 annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time